Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-19 · accession 0001062822-26-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-23 | 2026-02-19+ | LXRX | DEBBANE RAYMOND | Dir | P - Purchase | $1.47 | +150.0K | 1.70M | +10% | +$220.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | P | A | 100,000 | $1.48 | 1,804,186 | D | — | — | (F2) Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.49 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2026-02-19 | P | A | 50,000 | $1.44 | 1,704,186 | D | — | — | (F1) Represents a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.425 to $1.455 per share. The reporting person hereby undertakes to provide to the issuer, a security holder of the issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. |